Diabetes is a metabolic condition that is exponentially increasing worldwide. Current monitoring methods for diabetes are invasive, painful, and expensive. Herein, we present the first multipatient clinical trial that demonstrates clearly that tear fluid may be a valuable marker for systemic glucose measurements. The NovioSense Glucose Sensor, worn under the lower eye lid (inferior conjunctival fornix), is reported to continuously measure glucose levels in the basal tear fluid with good correlation to blood glucose values, showing clear clinical feasibility in both animals and humans. Furthermore, the polysaccharide coated device previously reported by our laboratory when worn, does not induce pain or irritation. In a phase II clinical trial, six patients with type 1 Diabetes Mellitus were enrolled and the capability of the device to measure glucose in the tear fluid was evaluated. The NovioSense Glucose Sensor gives a stable signal and the results correlate well to blood glucose values obtained from finger-prick measurements determined by consensus error grid analysis.

We describe a novel modular approach to a series of luminescent iridium complexes bearing triazole–pyridine-derived ligands that were conveniently prepared by using “click” chemistry. One, two or three triazole–pyridine units were effectively built into the heteroaromatic macromolecule using versatile acetylene- and azide-functionalised precursors. Using this approach, a series of iridium-derived molecules, that differ in the number of iridium centres, the structural characteristics of the cyclometalating ligand and the backbone, were synthesised. The preliminary photophysical properties of the prepared complexes indicate that there is only limited interaction (through space or through the backbone) between the iridium centres within one molecule and that each iridium centre retains its individual properties. The results show that our approach can be generally applied towards covalently linked multichromophoric systems with potential application, for instance, in the design and preparation of tunable light emitters. As a demonstration of this concept, a single molecule white-light emitter, constructed from two iridium centres (yellow emission) and a fluorene unit (blue emission), is presented.

Wearable devices (wearables) have recently gained significant traction and are predicted to dominate many areas of research over the next 5 years. Many wearables contain a host of sensors that feedback vital bodily parameters to a central system. Although many artificial sensors exist, the biggest challenge to medical wearables is to interface and harness the “big data” set from the human bodies own complex sensor network to better allow early diagnosis and/or treatment and prevention of diseases that have a huge economic burden on society such as type II diabetes. Cybernetics and medicine are joining their forces to overcome the new challenges in developing smarter, more intuitive and smaller sensors that interface with the human sensory system. This review is focused on the interface of devices to ion‐mediated transduction pathways both through G‐Coupled Protein Receptors and direct or mechanically transduced ion pathways.

This review demonstrates the application of nanocellulose-based polymer brushes in a range of different industries.

This paper presents a novel wireless tear glucose level sensor for diabetes patients. The miniaturized sensor can be worn non- invasively under the eye lid. It is composed of a chronoamperometric glucose sensor and an ASIC set with integrated potentiostat and transponder circuits. Wireless energy and data transmission according to the passive transponder standard ISO18000-3 is used to power and readout the sensor. A special coil shape enables high comfort for the patient. High integration level is achieved by a combination of antenna and sensor electrode wires. A complete demonstrator system including ASIC and sensor fabrication as well as assembly was manufactured and the function is demonstrated.